禮來(LLY.US)和諾和諾德(NVO.US)一路高歌 當前是否估值過高?
- 作者智通財經-
智通財經APP獲悉,禮來(LLY.US)和諾和諾德(NVO.US)股價近幾個月持續上漲,主要在於兩大巨頭各自生產的減肥或糖尿病藥物替扎帕肽(又名Zepbound)和司美格魯肽(又...
最新 | 高 | 低 | |||||
---|---|---|---|---|---|---|---|
200.6 | 201.3 | 199.0 | -0.5 | -0.25% | 1.11M | ||
976.0 | 988.8 | 975.6 | -13.8 | -1.39% | 212.04K | ||
1,045.0 | 1,059.5 | 1,035.5 | -13.0 | -1.23% | 391.12K | ||
927.2 | 928.9 | 900.0 | +23.9 | +2.65% | 2.69M | ||
11,505 | 11,830 | 11,425 | +75 | +0.66% | 28.67K | ||
428.7 | 434.7 | 426.4 | -6.7 | -1.54% | 559.44K | ||
11,150 | 11,410 | 11,030 | +110 | +1.00% | 7.93K | ||
2,002.0 | 2,036.0 | 2,002.0 | -39.0 | -1.91% | 104.41K | ||
216.4 | 222.3 | 215.2 | -4.9 | -2.21% | 455.79K | ||
193.8 | 194.7 | 186.4 | +2.2 | +1.12% | 2.48M | ||
335.0 | 350.0 | 334.0 | 0.0 | 0.00% | 452.48K | ||
144.0 | 144.0 | 141.4 | +2.0 | +1.41% | 791.93K | ||
854.8 | 859.2 | 848.6 | +4.8 | +0.56% | 181.87K | ||
127.9 | 130.1 | 126.2 | -2.3 | -1.77% | 503.79K | ||
540.0 | 545.0 | 539.5 | -4.5 | -0.83% | 115.39K | ||
1,148.0 | 1,173.0 | 1,144.0 | -21.5 | -1.84% | 136.14K | ||
2,642 | 2,718 | 2,604 | -30 | -1.12% | 56.59K | ||
130.20 | 131.70 | 129.10 | -0.70 | -0.53% | 398.29K | ||
415.50 | 417.90 | 408.20 | -4.00 | -0.95% | 640.96K |
智通財經APP獲悉,禮來(LLY.US)和諾和諾德(NVO.US)股價近幾個月持續上漲,主要在於兩大巨頭各自生產的減肥或糖尿病藥物替扎帕肽(又名Zepbound)和司美格魯肽(又...
智通財經APP獲悉,丹麥政府目前預計該國經濟今年將增長2.7%,幾乎是此前預期的兩倍。蓬勃發展的諾和諾德(NVO.US)加速了丹麥經濟增長。 丹麥經濟部上調了對2024年國內生產...
智通財經APP獲悉,中遠海運港口(01199)跌超3%,截至發稿,跌3.58%,報5.12港元,成交額7834.12萬港元。 消息面上,MSCI日前公佈2024年5月指數審議結果...